Quantitative analysis and clinico-pathological correlations of different dipeptide repeat protein pathologies in C9ORF72 mutation carriers

被引:177
作者
Mackenzie, Ian R. A. [1 ,2 ]
Frick, Petra [3 ]
Graesser, Friedrich A. [4 ]
Gendron, Tania F. [5 ]
Petrucelli, Leonard [5 ]
Cashman, Neil R. [6 ,7 ]
Edbauer, Dieter [8 ,9 ]
Kremmer, Elisabeth [8 ,10 ]
Prudlo, Johannes [11 ,12 ]
Troost, Dirk [13 ]
Neumann, Manuela [3 ,14 ]
机构
[1] Univ British Columbia, Dept Pathol, Vancouver, BC, Canada
[2] Vancouver Gen Hosp, Vancouver, BC, Canada
[3] German Ctr Neurodegenerat Dis DZNE, D-72076 Tubingen, Germany
[4] Univ Saarland, Inst Virol, Sch Med, Homburg, Germany
[5] Mayo Clin Florida, Dept Neurosci, Jacksonville, FL USA
[6] Univ British Columbia, Brain Res Ctr, Dept Med Neurol, Vancouver, BC V5Z 1M9, Canada
[7] German Ctr Neurodegenerat Dis DZNE, Munich, Germany
[8] Munich Cluster Syst Neurol SyNergy, Munich, Germany
[9] Univ Munich, Inst Metab Biochem, Munich, Germany
[10] Helmholtz Zentrum Munchen, Inst Mol Immunol, Munich, Germany
[11] German Ctr Neurodegenerat Dis DZNE, Rostock, Germany
[12] Univ Rostock, Dept Neurol, D-18055 Rostock, Germany
[13] Univ Amsterdam, Acad Med Ctr, Dept Neuropathol, NL-1105 AZ Amsterdam, Netherlands
[14] Univ Tubingen, Dept Neuropathol, Tubingen, Germany
基金
加拿大健康研究院;
关键词
AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; ANTISENSE RNA FOCI; HEXANUCLEOTIDE REPEAT; RAN TRANSLATION; CHROMOSOME; 9P; GGGGCC REPEAT; EXPANSION; DEMENTIA; TDP-43;
D O I
10.1007/s00401-015-1476-2
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Hexanucleotide repeat expansion in C9ORF72 is the most common genetic cause of frontotemporal dementia and motor neuron disease. One consequence of the mutation is the formation of different potentially toxic polypeptides composed of dipeptide repeats (DPR) (poly-GA, -GP, -GR, -PA, -PR) generated by repeat-associated non-ATG (RAN) translation. While previous studies focusing on poly-GA pathology have failed to detect any clinico-pathological correlations in C9ORF72 mutation cases, recent data from animal and cell culture models suggested that it may be only specific DPR species that are toxic and only when accumulated in certain intracellular compartments. Therefore, we performed a systematic clinico-pathological correlative analysis with counting of actual numbers of distinct types of inclusion (neuronal cytoplasmic and intranuclear inclusions, dystrophic neurites) for each DPR protein in relevant brain regions (premotor cortex, lower motor neurons) in a cohort of 35 C9ORF72 mutation cases covering the clinical spectrum from those with pure MND, mixed FTD/MND and pure FTD. While each DPR protein pathology had a similar pattern of anatomical distribution, the total amount of inclusions for each DPR protein varied remarkably (poly-GA > GP > GR > PR/PA), indicating that RAN translation seems to be more effective from sense than from antisense transcripts. Importantly, with the exception of moderate associations for the amount of poly-GA-positive dystrophic neurites with degeneration in the frontal cortex and total burden of poly-GA pathology with disease onset, no relationship was identified for any other DPR protein pathology with degeneration or phenotype. Biochemical analysis revealed a close correlation between insoluble DPR protein species and numbers of visible inclusions, while we did not find any evidence for the presence of soluble DPR protein species. Thus, overall our findings strongly argue against a role of DPR protein aggregation as major and exclusive pathomechanism in C9ORF72 pathogenesis. However, this does not exclude that DPR protein formation might be essential in C9ORF72 pathogenesis in interplay with other consequences associated with the C9ORF72 repeat expansion.
引用
收藏
页码:845 / 861
页数:17
相关论文
共 50 条
  • [41] Pathological assessments for the presence of hexanucleotide repeat expansions in C9ORF72 in Alzheimer's disease
    Davidson, Yvonne S.
    Robinson, Andrew C.
    Snowden, Julie S.
    Mann, David M. A.
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2013, 1
  • [42] Drosha Inclusions Are New Components of Dipeptide-Repeat Protein Aggregates in FTLD-TDP and ALS C9orf72 Expansion Cases
    Porta, Silvia
    Kwong, Linda K.
    Trojanowski, John Q.
    Lee, Virginia M. Y.
    JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2015, 74 (04) : 380 - 387
  • [43] Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion
    Waite, Adrian J.
    Baeumer, Dirk
    East, Simon
    Neal, James
    Morris, Huw R.
    Ansorge, Olaf
    Blake, Derek J.
    NEUROBIOLOGY OF AGING, 2014, 35 (07) : 1779.e5 - 1779.e13
  • [44] Longitudinal changes in network homogeneity in presymptomatic C9orf72 mutation carriers
    Waugh, Rebecca E.
    Danielian, Laura E.
    Shoukry, Rachel F. Smallwood
    Floeter, Mary Kay
    NEUROBIOLOGY OF AGING, 2021, 99 : 1 - 10
  • [45] Clinical and pathological features of familial frontotemporal dementia caused by C9ORF72 mutation on chromosome 9p
    Hsiung, Ging-Yuek R.
    DeJesus-Hernandez, Mariely
    Feldman, Howard H.
    Sengdy, Pheth
    Bouchard-Kerr, Phoenix
    Dwosh, Emily
    Butler, Rachel
    Leung, Bonnie
    Fok, Alice
    Rutherford, Nicola J.
    Baker, Matt
    Rademakers, Rosa
    Mackenzie, Ian R. A.
    BRAIN, 2012, 135 : 709 - 722
  • [46] The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome
    Gupta, Rahul
    Lan, Matthews
    Mojsilovic-Petrovic, Jelena
    Choi, Won Hoon
    Safren, Nathaniel
    Barmada, Sami
    Lee, Min Jae
    Kalb, Robert
    ENEURO, 2017, 4 (01)
  • [47] Prevalence of immunological diseases in a Finnish frontotemporal lobar degeneration cohort with the C9orf72 repeat expansion carriers and non-carriers
    Katisko, Kasper
    Solje, Eino
    Koivisto, Anne M.
    Kruger, Johanna
    Kinnunen, Tuure
    Hartikainen, Paivi
    Helisalmi, Seppo
    Korhonen, Ville
    Herukka, Sanna-Kaisa
    Haapasalo, Annakaisa
    Remes, Anne M.
    JOURNAL OF NEUROIMMUNOLOGY, 2018, 321 : 29 - 35
  • [48] FDG-PET in presymptomatic C9orf72 mutation carriers
    Popuri, Karteek
    Beg, Mirza Faisal
    Lee, Hyunwoo
    Balachandar, Rakesh
    Wang, Lei
    Sossi, Vesna
    Jacova, Claudia
    Baker, Matt
    Shahinfard, Elham
    Rademakers, Rosa
    Mackenzie, Ian R. A.
    Hsiung, Ging-Yuek R.
    NEUROIMAGE-CLINICAL, 2021, 31
  • [49] Longitudinal imaging in C9orf72 mutation carriers: Relationship to phenotype
    Floeter, Mary Kay
    Bageac, Devin
    Danielian, Laura E.
    Braun, Laura E.
    Traynor, Bryan J.
    Kwan, Justin Y.
    NEUROIMAGE-CLINICAL, 2016, 12 : 1035 - 1043
  • [50] Multiple pathways of toxicity induced by c9orf72 dipeptide repeat aggregates and G4C2 RNA in a cellular model
    Frottin, Frederic
    Perez-Berlanga, Manuela
    Hartl, F. Ulrich
    Hipp, Mark S.
    ELIFE, 2021, 10